Please enable JavaScript to continue using this application.

Compare $INO vs $TNXP | Chartloom

Compare

$INO vs $TNXP

Inovio Pharmaceuticals Inc · Tonix Pharmaceuticals Holding Corp

INO

Inovio Pharmaceuticals Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Compare $INO vs $TNXP

Comparing Inovio Pharmaceuticals Inc and Tonix Pharmaceuticals Holding Corp

INOInovio Pharmaceuticals Inc

TNXPTonix Pharmaceuticals Holding Corp

INOInovio Pharmaceuticals Inc

Market cap

$95M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.48x

Rev growth (TTM)

-100.0%

YTD performance

-32.0%

52W performance

-55.1%

FCF yield

-85.4%

TNXPTonix Pharmaceuticals Holding Corp

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.39x

Rev growth (TTM)

196.0%

YTD performance

-55.9%

52W performance

-67.5%

FCF yield

-135.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INO

TNXP

Detailed metrics comparison

INO

Inovio Pharmaceuticals Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

INO$95M

TNXP$116M

Enterprise Value

INO$63M

TNXP$-60M

Price

INO$1.15

TNXP$7.30

P/E Ratio

INON/A

TNXPN/A

P/S Ratio

INO423.69x

TNXP4.00x

EV/Sales

INO312.32x

TNXP-2.06x

EV/EBITDA

INO0.00x

TNXP0.00x

P/B Ratio

INO27.44x

TNXP0.69x

P/FCF Ratio

INON/A

TNXPN/A

EV/FCF

INO-0.78x

TNXP0.38x

PEG Ratio

INON/A

TNXPN/A

Forward P/E (NTM)

INON/A

TNXPN/A

Forward P/S (NTM)

INO2.48x

TNXP1.39x

Revenue (TTM)

INO$0

TNXP$29M

Revenue Growth (YoY)

INO-100.0%

TNXP196.0%

Forward Rev Growth

INO7491.0%

TNXP101.6%

Gross Margin (TTM)

INO58.9%

TNXP83.8%

Operating Margin (TTM)

INO0.0%

TNXP0.0%

EBITDA Margin (TTM)

INO0.0%

TNXP-561.1%

Net Margin (TTM)

INO0.0%

TNXP-548.6%

FCF Margin (TTM)

INON/A

TNXP-543.3%

Net Income (TTM)

INO$-67M

TNXP$-160M

FCF (TTM)

INO$-81M

TNXP$-158M

EPS (TTM)

INO-$0.83

TNXP-$9.60

ROE (TTM)

INO-19050.0%

TNXP-6899.0%

ROA (TTM)

INO-11105.0%

TNXP-6132.0%

ROIC (TTM)

INO-19050.0%

TNXP-6899.0%

Cash

INO$32M

TNXP$176M

Debt

INO$0

TNXP$0

Net Cash/Debt

INO$32M

TNXP$176M

Current Ratio (TTM)

INO1.00x

TNXP6.61x

Quick Ratio (TTM)

INO0.92x

TNXP6.13x

Debt/Equity (TTM)

INO0.00x

TNXP0.00x

Debt/Assets (TTM)

INO0.0%

TNXP0.0%

Interest Coverage (TTM)

INON/A

TNXPN/A

Net Debt/EBITDA (TTM)

INO0.00x

TNXP0.00x

Beta

INO1.68

TNXP1.87

52W Performance

INO-55.1%

TNXP-67.5%

YTD Performance

INO-32.0%

TNXP-55.9%

% from 52W High

INO-57.7%

TNXP-68.3%

% from 52W Low

INO104.2%

TNXP3.0%

Asset Turnover (TTM)

INO0.00x

TNXP0.11x

FCF Yield (TTM)

INO-85.4%

TNXP-135.9%

Earnings Yield (TTM)

INO-71.3%

TNXP-137.2%

Dividend Yield (TTM)

INON/A

TNXPN/A

Rule of 40

INO-100.0

TNXP-347.3

EV/GP/RG

INON/A

TNXPN/A

Ticker research

View INO research View TNXP research

Metric	INO Inovio Pharmaceuticals Inc	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$95M	$116M
Enterprise Value	$63M	$-60M
Price	$1.15	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	423.69x	4.00x
EV/Sales	312.32x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	27.44x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.48x	1.39x
Revenue & Growth
Revenue (TTM)	$0	$29M
Revenue Growth (YoY)	-100.0%	196.0%
Forward Rev Growth	7491.0%	101.6%
Profitability
Gross Margin (TTM)	58.9%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-561.1%
Net Margin (TTM)	0.0%	-548.6%
FCF Margin (TTM)	N/A	-543.3%
Net Income (TTM)	$-67M	$-160M
FCF (TTM)	$-81M	$-158M
EPS (TTM)	-$0.83	-$9.60
ROE (TTM)	-19050.0%	-6899.0%
ROA (TTM)	-11105.0%	-6132.0%
ROIC (TTM)	-19050.0%	-6899.0%
Financial Health
Cash	$32M	$176M
Debt	$0	$0
Net Cash/Debt	$32M	$176M
Current Ratio (TTM)	1.00x	6.61x
Quick Ratio (TTM)	0.92x	6.13x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	1.87
52W Performance	-55.1%	-67.5%
YTD Performance	-32.0%	-55.9%
% from 52W High	-57.7%	-68.3%
% from 52W Low	104.2%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.11x
FCF Yield (TTM)	-85.4%	-135.9%
Earnings Yield (TTM)	-71.3%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-347.3
EV/GP/RG	N/A	N/A
Ticker research	View INO research	View TNXP research

Valuation

P/S Ratio

TNXP

4.00x

INO

423.69x

EV/FCF

INO

-0.78x

TNXP

0.38x

Growth & revenue

Revenue Growth TTM

TNXP

196.0%

INO

-100.0%

Forward Revenue Growth

INO

7491.0%

TNXP

101.6%

Profitability & performance

Gross Margin

TNXP

83.8%

INO

58.9%

ROE

TNXP

-6899.0%

INO

-19050.0%

FCF Yield %

INO

-85.4%

TNXP

-135.9%

52-Week Performance

INO

-55.1%

TNXP

-67.5%

Detailed metrics comparison

INO

Inovio Pharmaceuticals Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

INO$95M

TNXP$116M

Enterprise Value

INO$63M

TNXP$-60M

Price

INO$1.15

TNXP$7.30

P/E Ratio

INON/A

TNXPN/A

P/S Ratio

INO423.69x

TNXP4.00x

EV/Sales

INO312.32x

TNXP-2.06x

EV/EBITDA

INO0.00x

TNXP0.00x

P/B Ratio

INO27.44x

TNXP0.69x

P/FCF Ratio

INON/A

TNXPN/A

EV/FCF

INO-0.78x

TNXP0.38x

PEG Ratio

INON/A

TNXPN/A

Forward P/E (NTM)

INON/A

TNXPN/A

Forward P/S (NTM)

INO2.48x

TNXP1.39x

Revenue (TTM)

INO$0

TNXP$29M

Revenue Growth (YoY)

INO-100.0%

TNXP196.0%

Forward Rev Growth

INO7491.0%

TNXP101.6%

Gross Margin (TTM)

INO58.9%

TNXP83.8%

Operating Margin (TTM)

INO0.0%

TNXP0.0%

EBITDA Margin (TTM)

INO0.0%

TNXP-561.1%

Net Margin (TTM)

INO0.0%

TNXP-548.6%

FCF Margin (TTM)

INON/A

TNXP-543.3%

Net Income (TTM)

INO$-67M

TNXP$-160M

FCF (TTM)

INO$-81M

TNXP$-158M

EPS (TTM)

INO-$0.83

TNXP-$9.60

ROE (TTM)

INO-19050.0%

TNXP-6899.0%

ROA (TTM)

INO-11105.0%

TNXP-6132.0%

ROIC (TTM)

INO-19050.0%

TNXP-6899.0%

Cash

INO$32M

TNXP$176M

Debt

INO$0

TNXP$0

Net Cash/Debt

INO$32M

TNXP$176M

Current Ratio (TTM)

INO1.00x

TNXP6.61x

Quick Ratio (TTM)

INO0.92x

TNXP6.13x

Debt/Equity (TTM)

INO0.00x

TNXP0.00x

Debt/Assets (TTM)

INO0.0%

TNXP0.0%

Interest Coverage (TTM)

INON/A

TNXPN/A

Net Debt/EBITDA (TTM)

INO0.00x

TNXP0.00x

Beta

INO1.68

TNXP1.87

52W Performance

INO-55.1%

TNXP-67.5%

YTD Performance

INO-32.0%

TNXP-55.9%

% from 52W High

INO-57.7%

TNXP-68.3%

% from 52W Low

INO104.2%

TNXP3.0%

Asset Turnover (TTM)

INO0.00x

TNXP0.11x

FCF Yield (TTM)

INO-85.4%

TNXP-135.9%

Earnings Yield (TTM)

INO-71.3%

TNXP-137.2%

Dividend Yield (TTM)

INON/A

TNXPN/A

Rule of 40

INO-100.0

TNXP-347.3

EV/GP/RG

INON/A

TNXPN/A

Ticker research

View INO research View TNXP research

Metric	INO Inovio Pharmaceuticals Inc	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$95M	$116M
Enterprise Value	$63M	$-60M
Price	$1.15	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	423.69x	4.00x
EV/Sales	312.32x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	27.44x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.48x	1.39x
Revenue & Growth
Revenue (TTM)	$0	$29M
Revenue Growth (YoY)	-100.0%	196.0%
Forward Rev Growth	7491.0%	101.6%
Profitability
Gross Margin (TTM)	58.9%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-561.1%
Net Margin (TTM)	0.0%	-548.6%
FCF Margin (TTM)	N/A	-543.3%
Net Income (TTM)	$-67M	$-160M
FCF (TTM)	$-81M	$-158M
EPS (TTM)	-$0.83	-$9.60
ROE (TTM)	-19050.0%	-6899.0%
ROA (TTM)	-11105.0%	-6132.0%
ROIC (TTM)	-19050.0%	-6899.0%
Financial Health
Cash	$32M	$176M
Debt	$0	$0
Net Cash/Debt	$32M	$176M
Current Ratio (TTM)	1.00x	6.61x
Quick Ratio (TTM)	0.92x	6.13x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	1.87
52W Performance	-55.1%	-67.5%
YTD Performance	-32.0%	-55.9%
% from 52W High	-57.7%	-68.3%
% from 52W Low	104.2%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.11x
FCF Yield (TTM)	-85.4%	-135.9%
Earnings Yield (TTM)	-71.3%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-347.3
EV/GP/RG	N/A	N/A
Ticker research	View INO research	View TNXP research